Utilitajiet

Żid mal-pubblikazzjonijiet tiegħi
Oħloq twissija
Link permanenti
Metadejta RDF opens-new-windowopens-new-window
Inkorpora fis-sit web
More
Cancel

Klassifikazzjoni tal-utent

Web Content Display

is-temporarily-unavailable

Publication Detail Portlet

Publication detail

Home

Il-liġi tal-UE

Niżżel

Written question E-2848/06 by Rebecca Harms (Verts/ALE) to the Commission. Possible adverse effects of inhaled insulin powder

Metadejta tal-pubblikazzjoni

M’hemm ebda dokument disponibbli biex jiġi ddawnlowdjat.

Dettalji tal-pubblikazzjoni
Pubblikazzjonijiet relatati

Ippubblikat: 2006-06-28
Awtur(i) korporattiv(i): Dejta provviżorja , Il-Parlament Ewropew
CELEX : 92006E002848

Publication Viewer

Viżwalizzatur tad-dokument

Note: Il-pubblikazzjoni ma tistax tintwera fil-viżwalizzatur tad-dokument. Verżjoni miftuħa fuq l-internet
Tista’ taċċessaha minn: Iddawnlowdjar u lingwi

Web Content Display

is-temporarily-unavailable

Utilitajiet

Publication detail

Written question E-2848/06 by Rebecca Harms (Verts/ALE) to the Commission. Possible adverse effects of inhaled insulin powder

Written question E-2848/06 by Rebecca Harms (Verts/ALE) to the Commission. Possible adverse effects of inhaled insulin powder

Metadejta tal-pubblikazzjoni

Lingwi u formati disponibbli

Viżwalizzatur tad-dokument